HERM ROSENMAN
CIK 1230057 · Chief Financial Officer · last filed 2026-04-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.36M
Companies
7
Total Filings
105
Lifetime Open-Market Net
-$27.09M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NTRA | Director | 20,558 | $212.07 | $4.36M | -$24.27M | 47 | 2026-04-28 |
| DermTech, Inc. (DMTK) Delisted | Director | 134,576 | $0.09 | $12.7K | $274.6K | 8 | 2023-06-05 |
| Oxford Immunotec Global PLC (OXFD) Delisted | Director | 4,081 | — | — | $0 | 7 | 2020-06-26 |
| VIVUS INC (VVUS) Delisted | Director | 36,168 | — | — | $159.0K | 21 | 2020-02-24 |
| GPRO | Senior VP, Finance & CFO | 0 | $0.77 | $0 | -$3.25M | 17 | 2012-08-02 |
| ARYx Therapeutics, Inc. (ARYX) Delisted | Director | — | — | — | $0 | 3 | 2010-05-03 |
| INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Director | — | $0.04 | — | $0 | 1 | 2007-09-14 |
Recent Filings · Page 10 of 11
105 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-02-14 | GPRO | Mixed | +1,509 | -$14.2K | EDGAR |
| 2010-08-18 | GPRO | Tax (F) | −1,833 | -$87.1K | EDGAR |
| 2010-05-03 | ARYx Therapeutics, Inc. (ARYX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-02-12 | GPRO | Grant (A) | — | $0 | EDGAR |
| 2009-10-21 | GPRO | Tax (F) | −568 | -$25.4K | EDGAR |
| 2009-08-19 | GPRO | Mixed | −177 | -$64.6K | EDGAR |
| 2009-05-01 | ARYx Therapeutics, Inc. (ARYX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-11-05 | GPRO | Tax (F) | −568 | -$26.6K | EDGAR |
| 2008-09-02 | GPRO | Tax (F) | −1,136 | -$68.5K | EDGAR |
| 2008-08-19 | GPRO | Grant (A) | +6,667 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.